This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sever, P. Search for Related Content PubMed PubMed Citation Articles by Sever, P. Pubmed/NCBI databases Medline Plus Health Information Blood Pressure Medicines High Blood Pressure Social Bookmarking                         What's this?

ACE inhibitors in hypertension: Still a shortage of evidence

Department of Clinical Pharmacology, Imperial College School of Medicine, St Mary's Hospital, London, UK, p.sever{at}ic.ac.uk

Key Words: hypertension • ACE inhibitors • coronary heart disease • clinical trials

References

• Collins R., Peto R. Antihypertensive drug therapy: Effects on Stroke and Coronary Heart Disease. In: Textbook of Hypertension Blackwell Scientific Publications 1994, UK. p1156-1164.
• Nayler WG Review of Preclinical Data of Calcium Channel Blockers and Atherosclerosis. J Cardiovasc Pharmacol 1999; 33 (Suppl 2): S7-11.1.
• Opie L. Angiotensin-Converting Enzyme Inhibitors: The Advances Continue. NewYork:Authors' Publishing House, 1999.
• World Health Organisation - International Society of Hypertension Blood Pressure Lowering Treatment Triallists ' Collaboration. Protocol for prospective collaborative overviews of major trials of blood-pressure-lowering treatments. J Hypertens 1998;16:127-137.[Web of Science][Medline] [Order article via Infotrieve]
• Hansson L., Lindholm LH, Niskanen L. et al., for the CAPPP Study Group, Principal results of the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;353:611-16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hansson L., Lindholm LH, Ekborn T., et al., for the STOP-Hypertension 2 study group. Lancet 1999;354:1751-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Davis BR, Cutler JA, Gordon DJ et al., for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). Am J Hypertens 1996;9:342-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• The Anglo Scandinavian Cardiac Outcomes Trial (ASCOT). Dahlof B., Sever PS, Poulter NR, Wedel H. on behalf of the ASCOT Steering Committee. Imperial College School of Medicine, London, UK. Abstract. AMJ 1998:11A-10A.
• Wood D., Durrington P., Poulter N., McInnes G., Rees A., Wray R. for the British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, and British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80:S1-S29.[Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 2, 117-118 (2000)
DOI: 10.3317/jraas.2000.012


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sever, P. Search for Related Content PubMed PubMed Citation Articles by Sever, P. Pubmed/NCBI databases Medline Plus Health Information Blood Pressure Medicines High Blood Pressure Social Bookmarking                         What's this?